Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells
- PMID: 24994473
- DOI: 10.1016/j.tiv.2014.06.011
Single pre-treatment with hypericin, a St. John's wort secondary metabolite, attenuates cisplatin- and mitoxantrone-induced cell death in A2780, A2780cis and HL-60 cells
Abstract
St. John's wort (SJW, Hypericum perforatum L.) is a commonly used natural antidepressant responsible for the altered toxicity of some anticancer agents. These interactions have been primarily attributed to the hyperforin-mediated induction of some pharmacokinetic mechanisms. However, as previously demonstrated by our group, hypericin induces the expression of two ABC transporters: multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein (BCRP). Because cisplatin (CDDP) and mitoxantrone (MTX) are potential substrates of ABC transporters, we investigated the effect of 24h hypericin pre-treatment on the cytotoxicity of CDDP and MTX in human cancer cell lines. CDDP-sensitive and -resistant ovarian adenocarcinoma cell lines A2780/A2780cis, together with HL-60 promyelocytic leukemia cells and ABCG2-over-expressing cBCRP subclone, were used in our experiments. We present CDDP cytotoxicity attenuated by hypericin pre-treatment in both A2780 and A2780cis cells and MTX cytotoxicity in HL-60 cells. In contrast, hypericin potentiated MTX-induced death in cBCRP cells. Interestingly, hypericin did not restore cell proliferation in rescued cells. Nevertheless, hypericin did increase the expression of MRP1 transporter in A2780 and A2780cis cells indicating the impact of hypericin on certain resistance mechanisms. Additionally, our results indicate that hypericin may be the potential substrate of BCRP transporter. In conclusion, for the first time, we report the ability of hypericin to affect the onset and/or progress of CDDP- and MTX-induced cell death, despite strong cell cycle arrest. Thus, hypericin represents another SJW metabolite that might be able to affect the effectiveness of anti-cancer drugs and that could interact with ABC transporters, particularly with BCRP.
Keywords: BCRP; Cisplatin; Hypericin; MRP; Mitoxantrone; St. John’s wort.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.Photochem Photobiol Sci. 2009 Dec;8(12):1716-23. doi: 10.1039/b9pp00086k. Epub 2009 Oct 23. Photochem Photobiol Sci. 2009. PMID: 20024169
-
Hypericin affects cancer side populations via competitive inhibition of BCRP.Biomed Pharmacother. 2018 Mar;99:511-522. doi: 10.1016/j.biopha.2018.01.074. Epub 2018 Feb 20. Biomed Pharmacother. 2018. PMID: 29665654
-
Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.Mol Cell Biochem. 2007 Feb;296(1-2):85-95. doi: 10.1007/s11010-006-9302-8. Epub 2006 Sep 8. Mol Cell Biochem. 2007. PMID: 16960658
-
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).Oncogene. 2003 Oct 20;22(47):7340-58. doi: 10.1038/sj.onc.1206938. Oncogene. 2003. PMID: 14576842 Review.
-
[Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].Ceska Slov Farm. 2007 Apr;56(2):62-6. Ceska Slov Farm. 2007. PMID: 17619301 Review. Czech.
Cited by
-
Antiproliferative Effects of St. John's Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies.Int J Mol Sci. 2020 Dec 25;22(1):146. doi: 10.3390/ijms22010146. Int J Mol Sci. 2020. PMID: 33375664 Free PMC article. Review.
-
Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of Hypericum spp.Cancers (Basel). 2021 Apr 1;13(7):1646. doi: 10.3390/cancers13071646. Cancers (Basel). 2021. PMID: 33916015 Free PMC article.
-
Multifunctional Nanoplatforms as a Novel Effective Approach in Photodynamic Therapy and Chemotherapy, to Overcome Multidrug Resistance in Cancer.Pharmaceutics. 2022 May 17;14(5):1075. doi: 10.3390/pharmaceutics14051075. Pharmaceutics. 2022. PMID: 35631660 Free PMC article. Review.
-
Structure-Based Classification and Anti-Cancer Effects of Plant Metabolites.Int J Mol Sci. 2018 Sep 6;19(9):2651. doi: 10.3390/ijms19092651. Int J Mol Sci. 2018. PMID: 30200668 Free PMC article. Review.
-
Hypericin in the Light and in the Dark: Two Sides of the Same Coin.Front Plant Sci. 2016 May 6;7:560. doi: 10.3389/fpls.2016.00560. eCollection 2016. Front Plant Sci. 2016. PMID: 27200034 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials